Prognostic significance of systemic immune-inflammation index- based nomogram for early stage hepatocellular carcinoma after radiofrequency ablation | Zendy

Yujing Xin | Zendy; Yi Yang | Zendy; Ning Liu | Zendy; Yi Chen | Zendy; Yanan Wang | Zendy; Xinyuan Zhang | Zendy; Xiao Li | Zendy; Xiang Zhou | Zendy

Open Access

Prognostic significance of systemic immune-inflammation index- based nomogram for early stage hepatocellular carcinoma after radiofrequency ablation

Author(s) -

Yujing Xin,

Yi Yang,

Ning Liu,

Yi Chen,

Yanan Wang,

Xinyuan Zhang,

Xiao Li,

Xiang Zhou

Publication year - 2021

Publication title -

journal of gastrointestinal oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.084

H-Index - 39

eISSN - 2219-679X

pISSN - 2078-6891

DOI - 10.21037/jgo-20-342

Subject(s) - nomogram , medicine , hepatocellular carcinoma , stage (stratigraphy) , receiver operating characteristic , multivariate analysis , gastroenterology , oncology , univariate analysis , lymphocyte , t stage , milan criteria , radiofrequency ablation , ablation , overall survival , liver transplantation , transplantation , paleontology , biology

Radiofrequency ablation (RFA) is the recommended treatment for early stage hepatocellular carcinoma (HCC), and the prognostic value of systemic immune-inflammation index (SII) in early stage HCC is not discussed. Therefore, the purpose of the study is to explore the prognostic value of SII based on lymphocyte, neutrophil, and platelet counts in patients with HCC after RFA.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research